Aquestive Therapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2021 | — | -68.2% | -138.8% |
| FY2022 | 59.3% | -88.2% | -114.1% |
| FY2023 | 58.8% | -29.9% | -15.6% |
| FY2024 | 69.0% | -53.5% | -76.7% |
| FY2025 | 58.3% | -159.5% | -188.1% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2021 | — | -68.2% | -138.8% |
| FY2022 | 59.3% | -88.2% | -114.1% |
| FY2023 | 58.8% | -29.9% | -15.6% |
| FY2024 | 69.0% | -53.5% | -76.7% |
| FY2025 | 58.3% | -159.5% | -188.1% |